First-Line Biologics for Moderate-to-Severe Psoriasis First-Line Biologics for Moderate-to-Severe Psoriasis

Multiple therapeutic options exist for moderate-to-severe psoriasis, each with unique benefits and limitations. This review offers guidance on choosing the optimal therapy for your patients.American Journal of Clinical Dermatology

Source: Medscape Today Headlines - February 22, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news